Literature DB >> 30030185

Zebrafish models: do we have valid paradigms for depression?

Murilo S de Abreu1, Ashton J Friend2, Konstantin A Demin3, Tamara G Amstislavskaya4, Wandong Bao5, Allan V Kalueff6.   

Abstract

Depression is a wide-spread, debilitating psychiatric disorder. Mainly rodent-based, experimental animal models of depression are extensively used to probe the pathogenesis of this disorder. Here, we emphasize the need for innovative approaches to studying depression, and call for a wider use of novel model organisms, such as the zebrafish (Danio rerio), in this field. Highly homologous to humans and rodents, zebrafish are rapidly becoming a valuable tool in translational neuroscience research, but have only recently been utilized in depression research. Multiple conceptual and methodological problems, however, arise in relation to separating putative zebrafish depression-like states from motor and social deficits or anxiety. Here, we examine recent findings and the existing challenges in this field, to encourage further research and the use of zebrafish as novel organisms in cross-species depression modeling.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Animal model; Biological psychiatry; Depression; Translational neuroscience; Zebrafish

Mesh:

Year:  2018        PMID: 30030185     DOI: 10.1016/j.vascn.2018.07.002

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  9 in total

Review 1.  Fish self-awareness: limits of current knowledge and theoretical expectations.

Authors:  Pavla Hubená; Pavel Horký; Ondřej Slavík
Journal:  Anim Cogn       Date:  2021-10-15       Impact factor: 3.084

Review 2.  Modelling ADHD-Like Phenotypes in Zebrafish.

Authors:  Barbara D Fontana; William H J Norton; Matthew O Parker
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Zebrafish Model for Studying Dexamethasone-Induced Muscle Atrophy and Preventive Effect of Maca (Lepidium meyenii).

Authors:  Bomi Ryu; Jun-Geon Je; You-Jin Jeon; Hye-Won Yang
Journal:  Cells       Date:  2021-10-25       Impact factor: 6.600

Review 4.  Sleep Disturbances and Depression Are Co-morbid Conditions: Insights From Animal Models, Especially Non-human Primate Model.

Authors:  Meng Li; Jieqiong Cui; Bonan Xu; Yuanyuan Wei; Chenyang Fu; Xiaoman Lv; Lei Xiong; Dongdong Qin
Journal:  Front Psychiatry       Date:  2022-01-25       Impact factor: 4.157

Review 5.  Zebrafish, Medaka and Turquoise Killifish for Understanding Human Neurodegenerative/Neurodevelopmental Disorders.

Authors:  Kazuki Kodera; Hideaki Matsui
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

6.  Towards Modeling Anhedonia and Its Treatment in Zebrafish.

Authors:  Murilo S de Abreu; Fabiano Costa; Ana C V V Giacomini; Konstantin A Demin; Konstantin N Zabegalov; Gleb O Maslov; Yuriy M Kositsyn; Elena V Petersen; Tatiana Strekalova; Denis B Rosemberg; Allan V Kalueff
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

Review 7.  A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment.

Authors:  Rosario Licitra; Maria Marchese; Valentina Naef; Asahi Ogi; Marco Martinelli; Claudia Kiferle; Baldassare Fronte; Filippo Maria Santorelli
Journal:  Biomedicines       Date:  2022-07-28

8.  Investigation of alpl expression and Tnap-activity in zebrafish implies conserved functions during skeletal and neuronal development.

Authors:  Barbara Ohlebusch; Angela Borst; Daniel Liedtke; Stephanie Graser; Tina Frankenbach; Eva Klopocki; Franz Jakob
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

9.  Modulation of behavioral and neurochemical responses of adult zebrafish by fluoxetine, eicosapentaenoic acid and lipopolysaccharide in the prolonged chronic unpredictable stress model.

Authors:  Konstantin A Demin; Tatiana O Kolesnikova; David S Galstyan; Nataliya A Krotova; Nikita P Ilyin; Ksenia A Derzhavina; Nataliia A Levchenko; Tatyana Strekalova; Murilo S de Abreu; Elena V Petersen; Maria Seredinskaya; Yulia V Cherneyko; Yuriy M Kositsyn; Dmitry V Sorokin; Konstantin N Zabegalov; Mikael S Mor; Evgeniya V Efimova; Allan V Kalueff
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.